Showing results (191-200 of 289) with videos related to

Sort By:
Pageof 29
Investigational New Drugs|July 1, 1989
A phase II study of spirogermanium in patients with advanced malignant lymphomaC Sessa, W ten Bokkel Huinik, M Clavel, et al.
Annals of Hematology|August 21, 2013
Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)M Mian, D Capello, M B Ventre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Anthracycline-based chemotherapy as primary treatment for intravascular lymphomaA J M Ferreri, E Campo, A Ambrosetti, et al.
Oncology|January 1, 1982
Combination hormonotherapy with tamoxifen and fluoxymesterone in patients with advanced breast cancer relapsing on hormonotherapyA Goldhirsch, U Leuenberger, H J Ryssel, et al.
Cancer Journal (Sudbury, Mass.)|January 10, 2002
Role of angiogenesis inhibitors in acute myeloid leukemiaW Fiedler, P Staib, R Kuse, et al.
Schweizerische Medizinische Wochenschrift|September 5, 1981
[Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213]R Joss, A Goldhirsch, F Cavalli, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolitesM Ghielmini, E Colli, G Bosshard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2016
ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemiaM Ladetto, C Buske, M Hutchings, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1995
Granulocyte growth factors: achieving a consensusM Boogaerts, F Cavalli, H Cortés-Funes, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1987
A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neckR Abele, H P Honegger, R Grossenbacher, et al.
Pageof 29